1-4.5 mg/kg IV slow (over 60 sec), or 1-2 mg/kg IV at 0.5 mg/kg/min
Induction of anesthesia (IM)
adult
6.5-13 mg/kg IM
Maintenance of anesthesia
adult
one-half to full induction dose, repeat PRN
Renal Undefined
Hepatic Undefined
Instructions
Administer by/under direction of clinicians experienced in general anesthesia; continuously monitor vital signs; emergency airway equipment immediately available
Do not give 100 mg/mL concentration IV without proper dilution; use immediately after dilution
Contraindications
Conditions where a significant elevation of blood pressure would be a serious hazard
Cautions
Hemodynamic instability (transient BP/HR/cardiac index rise; also hypotension, arrhythmias)
Emergence reactions/postoperative confusional states
Respiratory depression with overdose or too-rapid administration
Reflexes not suppressed—avoid as sole agent for pharynx/larynx/bronchial procedures
Pediatric neurotoxicity with use >3 hours in children ≤3 yr
Drug-induced liver injury
Adverse reactions
Elevated BP/HR/cardiac index
Emergence reactions (postoperative delirium)
Nausea, vomiting, anorexia
Enhanced muscle tone/spasms
Diplopia, nystagmus, raised intraocular pressure
Anaphylaxis
Pregnancy Not recommended; animal data show possible fetal harm—avoid in pregnancy, labor, and delivery
Lactation Undefined
NO BOXED WARNINGS
Principal riskEmergence reactions; abuse liability
Defining liabilityDissociation, sedation, blood-pressure and heart-rate elevation, emergence reactions and abuse/misuse potential; respiratory depression risk rises with other CNS depressants.